These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Peroxiredoxin 1 promotes pancreatic cancer cell invasion by modulating p38 MAPK activity. Taniuchi K; Furihata M; Hanazaki K; Iwasaki S; Tanaka K; Shimizu T; Saito M; Saibara T Pancreas; 2015 Mar; 44(2):331-40. PubMed ID: 25426613 [TBL] [Abstract][Full Text] [Related]
33. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma]. Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220 [TBL] [Abstract][Full Text] [Related]
34. Chronic pancreatitis is associated with disease-specific regulatory T-cell responses. Schmitz-Winnenthal H; Pietsch DH; Schimmack S; Bonertz A; Udonta F; Ge Y; Galindo L; Specht S; Volk C; Zgraggen K; Koch M; Büchler MW; Weitz J; Beckhove P Gastroenterology; 2010 Mar; 138(3):1178-88. PubMed ID: 19931255 [TBL] [Abstract][Full Text] [Related]
35. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody]. Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545 [TBL] [Abstract][Full Text] [Related]
36. Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma. Raj D; Yang MH; Rodgers D; Hampton EN; Begum J; Mustafa A; Lorizio D; Garces I; Propper D; Kench JG; Kocher HM; Young TS; Aicher A; Heeschen C Gut; 2019 Jun; 68(6):1052-1064. PubMed ID: 30121627 [TBL] [Abstract][Full Text] [Related]
37. Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines. Bassagañas S; Allende H; Cobler L; Ortiz MR; Llop E; de Bolós C; Peracaula R Cytokine; 2015 Sep; 75(1):197-206. PubMed ID: 25934648 [TBL] [Abstract][Full Text] [Related]
38. In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens. Brugiapaglia S; Bulfamante S; Curcio C; Arigoni M; Calogero R; Bonello L; Genuardi E; Spadi R; Satolli MA; Campra D; Giordano D; Cappello P; Cordero F; Novelli F Front Immunol; 2024; 15():1427424. PubMed ID: 39176093 [TBL] [Abstract][Full Text] [Related]
39. Immune selection in murine tumors. Ph.d thesis. Svane IM; Engel AM APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251 [TBL] [Abstract][Full Text] [Related]
40. Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes. Peiper M; Goedegebuure PS; Alldinger I; Knoefel WT; Izbicki JR; Eberlein TJ Anticancer Res; 2002; 22(6A):3357-63. PubMed ID: 12530087 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]